Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.2680
+0.0007 (+0.26%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Cybin to Host Key Opinion Leader Webinar on June 9, 2022
June 02, 2022
From
Cybin Inc.
Via
Business Wire
Oregon Adopts First Installment of Psilocybin Rules
June 01, 2022
Via
Investor Brand Network
How Your Mental Health May Benefit from a Digital Detox
May 31, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Completes Major Step in Advancement of CYB003 for the Treatment of Major Depressive Disorder
May 31, 2022
Via
Investor Brand Network
Exposures
Product Safety
Takeaways from Benzinga’s Psychedelics Capital Conference
May 16, 2022
Via
Investor Brand Network
Study Discovers Mechanisms Behind Relapse After Treatment of MDD
May 12, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) and Kernel Report Result of Study Measuring Ketamine’s Effects on the Brain
May 31, 2022
Via
Investor Brand Network
Exposures
COVID-19
Cybin Submits IND Application to FDA for its Phase 1/2a First-in-Human Trial of CYB003 for the Treatment of Major Depressive Disorder
May 31, 2022
From
Cybin
Via
Business Wire
VC Executive Shares Insights into Legal Psychedelics Landscape
May 27, 2022
Via
Investor Brand Network
Exposures
COVID-19
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Efforts Boosted by New Study Indicating Effectiveness of Psychedelic Compounds
May 26, 2022
Via
Investor Brand Network
Research Finds That Mushrooms May Have Their Own Language
May 03, 2022
Via
Investor Brand Network
CSIRO to Collaborate with Biotechnology Firms on Psychedelic Research
May 24, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Partners to Help Accelerate Regulatory Pathway of CYB003
May 23, 2022
Via
Investor Brand Network
Study Finds That Some Mental Disorders Share Genetic Profiles
May 20, 2022
Via
Investor Brand Network
Study Finds Mindfulness, Psychedelic Encounters Beneficial for Mental Well-Being
May 19, 2022
Via
Investor Brand Network
Study Finds Alcohol Cravings Get Stronger After Consumption during Withdrawal
May 17, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in May 18 NYSE Trading Bell Ceremony
May 17, 2022
Via
Investor Brand Network
Cybin to Participate in NYSE Trading Bell Ceremony on May 18, 2022
May 17, 2022
From
Cybin Inc.
Via
Business Wire
Study Indicates People Are Cautious About Psilocybin Therapy, More Awareness Needed
May 11, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright Global Investment Conference
May 11, 2022
Via
Investor Brand Network
Cybin to Present at the H.C. Wainwright Global Investment Conference on May 25, 2022
May 11, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Kernel Share Preliminary Results from Flow Feasibility Study
May 10, 2022
Via
Investor Brand Network
American Billionaire Entrepreneurs Bet Millions on Psychedelics
May 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...
Via
FinancialNewsMedia
Exposures
Product Safety
U.S. Army Sued Over Discharging Soldiers with Substance-Abuse Issues
May 09, 2022
Via
Investor Brand Network
Topics
Lawsuit
Exposures
Financial
Legal
Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial
May 06, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy
May 05, 2022
Via
Investor Brand Network
Cybin Announces CYB003 Poster to be Presented at the ‘From Research to Reality’ Global Summit on Psychedelic-Assisted Therapies and Medicine
May 05, 2022
From
Cybin Inc.
Via
Business Wire
Study Says Antidepressants Don’t Meaningfully Improve Depressed People’s Well-Being
May 04, 2022
Via
Investor Brand Network
Vancouver Island University to Expand Psychedelic Mental Healthcare Program
April 29, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape
April 28, 2022
Via
Investor Brand Network
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.